- Our Services
-
Patients and Families
- Get Directions
- Parking
- Childrens Locations
- Getting Around
- Guidelines for Visitors
- Contact a Patient
- Contact Children's
- Send an e-Card
- Gift Shop
Planning a Visit
- Find a Doctor
- Make an Appointment
- Child Health A-Z
- Community Ed.Classes
- Injury Prevention
- International Patients
- Medical Records
- Patient Handbook
- Patient Procedures
Parents
- For Health Professionals
- Research
- Ways to Give
- News
Research
Urinary Tract Infection NIH Observational Study
Purpose
|
The purpose of the Careful Urinary Tract Infection Evaluation (UTI) study is to help doctors identify children with urinary tract infections (UTIs) who might be more likely to get kidney scars. This could help children with UTIs stay healthy.
Study Description
UTIs are the most common serious bacterial infections in young children. In children younger than 6 years of age, 70,000 to 180,000 will have a UTI each year. Approximately two-thirds of young children with febrile UTIs will have an infection involving the kidneys and ureters; between 15% and 52% of these children will develop subsequent kidney scarring.
The UTI study is an observational study developed to understand why some children develop kidney scars after UTIs. In recent years, our understanding of the relationship of UTI and renal scarring, and current strategies for managing children with UTI have been challenged. Understanding which children are at the greatest risk of renal scarring after a UTI may allow us to provide more targeted therapies and interventions. Furthermore, by saving urine and blood in an NIH repository, we will create future opportunities to examine the genetic determinants of renal scarring in all children with UTI.
- UTI Additional Resources
- Careful Urinary Tract Infection Evaluation Frequently Asked Questions (PDF)
- Study Personnel Directory (PDF)
Eligibility Criteria
- At least 2 months of age, but less than 6 years old
- 1st or 2nd UTI with either fever or symptoms
- No history of VUR
- No history of other renal injury or serious disease
- No allergies to sulfa medications
- Meet a few additional eligibility requirements
Enroll
For more information or to enroll, contact Alejandro Hoberman, MD, Chief, Division of General Academic Pediatrics, at 412-999-3277.
Toolkit for PhysiciansHow to refer your next patient with UTI:
|
Last Update
January 22, 2010
January 22, 2010

Child Abuse Expert Appointed to Task Force
Dr. Hackam Receives Award to Generate an Artificial Intestine
International Expert Named Chief of Ophthalmology